Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aethlon Medical (AEMD)

Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,381
  • Shares Outstanding, K 13,962
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,210 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.90
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.82
  • Most Recent Earnings $-0.20 on 11/13/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.21
  • Low Estimate -0.23
  • Prior Year -1.37
  • Growth Rate Est. (year over year) +83.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3625 +11.53%
on 10/24/24
0.4649 -13.04%
on 11/11/24
+0.0003 (+0.07%)
since 10/22/24
3-Month
0.3300 +22.52%
on 09/23/24
0.6100 -33.72%
on 08/26/24
-0.1076 (-21.02%)
since 08/22/24
52-Week
0.2375 +70.23%
on 08/05/24
2.3499 -82.80%
on 12/28/23
-1.2857 (-76.08%)
since 11/22/23

Most Recent Stories

More News
Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - November 14, 2024) - Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases a snapshot...

AEMD : 0.4043 (+4.90%)
Innovative Medical Technology Advances with First Patient Enrollments

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - November 12, 2024) - Investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future of medical technology...

AEMD : 0.4043 (+4.90%)
Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 19, 2024) - Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments...

AEMD : 0.4043 (+4.90%)
Innovation Driving Cancer's Solid Tumors Market

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 17, 2024) - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at news and developments...

AEMD : 0.4043 (+4.90%)
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - August 12, 2024) - Investorideas.com, a go-to investing platform covering biotech and medical technology issues a snapshot on recent news...

AEMD : 0.4043 (+4.90%)
What's Next in Treatments for Cancer Patients with Solid Tumors?

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 20, 2024) - Investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future treatment of solid...

AEMD : 0.4043 (+4.90%)
The Hunt for Virus Treatments Continues Post Covid-19

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 7, 2024) - Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments...

AEMD : 0.4043 (+4.90%)
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 3, 2024) - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at medical device advancements...

AEMD : 0.4043 (+4.90%)
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral...

AEMD : 0.4043 (+4.90%)
Aethlon Announces Reverse Stock Split

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...

AEMD : 0.4043 (+4.90%)

Business Summary

Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development...

See More

Key Turning Points

3rd Resistance Point 0.4667
2nd Resistance Point 0.4433
1st Resistance Point 0.4238
Last Price 0.4043
1st Support Level 0.3809
2nd Support Level 0.3575
3rd Support Level 0.3380

See More

52-Week High 2.3499
Fibonacci 61.8% 1.5430
Fibonacci 50% 1.2937
Fibonacci 38.2% 1.0444
Last Price 0.4043
52-Week Low 0.2375

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar